Clinical Data Interchange Standards Consortium Inc
- Assets
- $4.0m
- Revenue
- $9.3m
- Investments
- $0.0
- Employees
- 46
- Location
- Austin, TX
- Founding
- 11/2011
- Data as of
- 12/2023
- EIN
- 04-3503931
Organization Overview
Clinical Data Interchange Standards Consortium Inc is located in Austin, TX. The organization was established in 2011. According to its NTEE Classification (E05) the organization is classified as: Research Institutes & Public Policy Analysis, under the broad grouping of Health Care and related organizations. As of 12/2023, Clinical Data Interchange Standards Consortium Inc employed 46 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Clinical Data Interchange Standards Consortium Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Clinical Data Interchange Standards Consortium Inc generated $9.3m in total revenue. This represents relatively stable growth, over the past 9 years the organization has increased revenue by an average of 4.1% each year. All expenses for the organization totaled $11.2m during the year ending 12/2023. While expenses have increased by 6.4% per year over the past 9 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
THE CDISC MISSION IS TO DEVELOP AND SUPPORT GLOBAL, PLATFORM-INDEPENDENT DATA STANDARDS THAT ENABLE INFORMATION SYSTEM INTEROPERABILITY TO IMPROVE MEDICAL RESEARCH AND RELATED AREAS OF HEALTHCARE.
Describe the Organization's Program Activity:
Part 3 - Line 4a
TECHNICAL - TO DATE, CDISC HAS DEVELOPED THERAPEUTIC AREA STANDARDS FOR OVER 44 DISEASE AREAS AND WE CONTINUE TO UPDATE AND EXPAND THESE STANDARDS WHEN POSSIBLE. IN 2023, CDISC CONTINUES TO DEVELOP SIGNIFICANT NEW VERSIONS OF THE CDISC FOUNDATIONAL STANDARDS (SEND, CDASH, SDTM, SDTMIG, ADAM, CONTROLLED TERMINOLOGY AND DATA EXCHANGE STANDARDS). THE TRIAL MASTER FILE REFERENCE MODEL (TMF RM) STANDARD HAS BECAME PART OF THE CDISC SUITE OF STANDARDS.CDISC RELEASED SEVERAL UPDATES TO THE CDISC LIBRARY TO ADD NEW FEATURES AS WELL AS NEW VERSIONS OF THE STANDARDS. CDISC CORE RULE ENGINE AND RULE EDITOR SOFTWARE HAS RELEASED AS OPEN SOURCE AND THE TEAM CONTINUES TO MAKE PROGRESS. FOR THE CDISC THE DIGITAL DATA FLOW PROJECT WE REALEASED A REFERENCE ARCHITECTURE AS A STANDARD AND ARE WORKING ON VERSION 3. CDISC CONTINUES TO RUN NUMEROUS HACKATHONS AND WORKSHOPS TO PROMOTE, SUPPORT, AND SOMETIMES SPONSOR OPEN-SOURCE SOFTWARE FOCUSED ON IMPLEMENTING OR DEVELOPING THE CDISC STANDARDS TO DRIVE INNOVATION.
PARTNERSHIPS & COLLABORATION - CDISC HAS OVER 530 ACTIVE MEMBERORGANIZATIONS. OUR MEMBERS' SUPPORT ENSURES THAT THE CDISC STANDARDSREMAIN OPEN AND FREE. MEMBERSHIP DUES ALLOW CDISC TO ACCOMPLISH THEPROGRAM SERVICES MENTIONED ABOVE. CDISC ALSO WORKS CLOSELY WITHREGULATORS AROUND THE WORLD TO ENSURE THAT CDISC STANDARDS FACILITATETHE E-SUBMISSION REVIEW PROCESS AND SUPPORT THE APPROVAL OF NEW CURESAND TREATMENTS.
EDUCATION - IN 2023, CDISC EDUCATION HELD THE MOST LIVE ON-LINE TRAINING EVENTS IN PROGRAM HISTORY WITH OVER 130 VIRTUAL TRAINING EVENTS LED THROUGHOUT THE YEAR AND OVER 1200 VIRTUAL ATTENDEES. THE EDUCATION TEAM MIGRATED TO A NEW E-COMMERCE SYSTEM AND UPGRADED THE CDISC LEARNING SYSTEM TO THE LATEST VERSION FOR THE FIRST TIME SINCE 2018, ALLOWING FOR EASIER ACCESS AND NEW LEARNING TOOLS FOR THE CDISC COMMUNITY.
EVENTS - CDISC HOSTED THREE VIRTUAL AND ONE IN-PERSON CONFERENCE IN 2023. THESE CONFERENCES WERE "INTERCHANGES," INDIVIDUALLY FOCUSED ON EUROPE, JAPAN, CHINA AND UNITED STATES MARKETS. THE EVENTS PROMOTED RECENT ADVANCEMENTS BY CDISC STANDARDS TEAMS, CDISC MEMBERS AND INDEPENDENT DEVELOPERS. ATTENDEES CAME FROM VARIOUS ORGANIZATIONS IN PHARMACEUTICAL, CRO, TECHNOLOGY, ACADEMIC AND BIOTECH SECTORS. CDISC ALSO SUPPORTED NON-CDISC EVENTS THROUGHOUT THE YEAR TO FURTHER PROMOTE THE AIMS OF THE ORGANIZATION TO THE BROADER CLINICAL RESEARCH COMMUNITY.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Erik Pulkstenis Chair | OfficerTrustee | 2 | $0 |
Chris Decker Chair-Elect | OfficerTrustee | 2 | $0 |
Pam Howard Past-Chair | OfficerTrustee | 2 | $0 |
Christina Reith Director | Trustee | 2 | $0 |
Mihoko Okada Director | Trustee | 2 | $0 |
Wenjun Bao Director | Trustee | 2 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Data4knowledge Aps Standards Development Consulting Service | 12/30/23 | $314,631 |
Lex Jansen Conslting Llc Standards Development Consulting Service | 12/30/23 | $165,130 |
Eclipse Database Consultants Standards Development Consulting Service | 12/30/23 | $197,588 |
Accurate Systems Standards Development Consulting Service | 12/30/23 | $131,581 |
Pour Over Productions Standards Development Consulting Service | 12/30/23 | $141,213 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $2,952,817 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $448,785 |
| All other contributions, gifts, grants, and similar amounts not included above | $1,389,737 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $4,791,339 |
| Total Program Service Revenue | $4,513,613 |
| Investment income | $28,176 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $9,333,128 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $1,300,846 |
| Compensation of current officers, directors, key employees. | $472,306 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $4,696,761 |
| Pension plan accruals and contributions | $191,736 |
| Other employee benefits | $498,370 |
| Payroll taxes | $418,387 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $2,500 |
| Fees for services: Accounting | $65,905 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $2,181,080 |
| Advertising and promotion | $0 |
| Office expenses | $63,762 |
| Information technology | $221,813 |
| Royalties | $0 |
| Occupancy | $135,054 |
| Travel | $166,224 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $14,058 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $31,129 |
| Insurance | $0 |
| All other expenses | $14,737 |
| Total functional expenses | $11,224,779 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $1,219,676 |
| Savings and temporary cash investments | $1,163,483 |
| Pledges and grants receivable | $62,590 |
| Accounts receivable, net | $505,090 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $130,625 |
| Net Land, buildings, and equipment | $52,756 |
| Investments—publicly traded securities | $845,349 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $3,979,569 |
| Accounts payable and accrued expenses | $868,188 |
| Grants payable | $0 |
| Deferred revenue | $1,332,739 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $100,000 |
| Total liabilities | $2,300,927 |
| Net assets without donor restrictions | $1,678,642 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $3,979,569 |